Journal
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
Volume 7, Issue 6, Pages 796-804Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s13346-017-0386-3
Keywords
Electrospun fibers; Contraception; STIs; Infection; Treatment; Prevention; Female reproductive health
Funding
- NIH/NIAID [AI112002]
- Bill and Melinda Gates Foundation [OPP1067729, OPP1110945]
- Bill and Melinda Gates Foundation [OPP1067729, OPP1110945] Funding Source: Bill and Melinda Gates Foundation
Ask authors/readers for more resources
Here, we present the current challenges in women's reproductive health and the current state-of-the-art treatment and prevention options for STI prevention, contraception, and treatment of infections. We discuss how the versatile platform of electrospun fibers can be applied to each challenge, and postulate at how these technologies could be improved. The void of approved electrospun fiber-based products yields the potential to apply this useful technology to a number of medical applications, many of which are relevant to women's reproductive health. Given the ability to tune drug delivery characteristics and three-dimensional geometry, there are many opportunities to pursue new product designs and routes of administration for electrospun fibers. For each application, we provide an overview of the versatility of electrospun fibers as a novel dosage form and summarize their advantages in clinical applications. We also provide a perspective on why electrospun fibers are well-suited for a variety of applications within women's reproductive health and identify areas that could greatly benefit from innovations with electrospun fiber-based approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available